CryoTherapeutics SA

CryoTherapeutics SA

Private
BelgiumHealthcare & Life Scienceshttps://cryotherapeutics.com

Last Round

Series B

Extension

Apr 2, 2024

Total Funding Raised

$27.44M

Company Overview

CryoTherapeutics SA is a medical device company developing a catheter-based cryotherapy system designed to treat atherosclerotic plaque that causes heart attacks by delivering cryoenergy to the coronary arteries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

catheter-based cryotherapycryotherapy systemvulnerable plaque stabilizationcoronary artery diseaseinterventional cardiologyimplant-free treatmentintracoronary catheterheart attack preventionmedtechatherosclerotic plaqueCE Markrazor-and-blades modelcath lab equipmentmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CryoTherapeutics SA Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CryoTherapeutics SA Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionApr 2, 2024
VC RoundFeb 17, 2022
Series BJun 27, 2019
Series A ExtensionMay 6, 2014
Series AMar 21, 2013
Seed
Dec 1, 2009

Key People

Founding team and executive leadership

Emmanuel Dagneaux

Chief Financial Officer

Executive Team

CryoTherapeutics SA Investors

Notable investors and investment history

InvestorRounds
NoshaqSeries B, VC Round, Series B Extension
Charité Biomedical FundSeries A
Getz BrothersSeries B, Series A, Series A Extension
NRW.BankSeries A, VC Round, Series B Extension, Series A Extension
Peppermint Venture PartnersSeries B, VC Round, Series B Extension, Series A Extension
GED VenturesSeries B Extension
KfWVC Round, Series B Extension, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 21, 2025

    Launched ICECAP in partnership with SpectraWAVE and CRF.

  • Nov 21, 2025

    Partnered with SpectraWAVE and CRF to launch ICECAP.

CryoTherapeutics SA Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CryoTherapeutics SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CryoTherapeutics SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range25
Year Founded2009
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.